Dr. Daniel P. Bax, MD

Dr. Bax practices at Breast Care of Western New York in Orchard Park, New York.

Dr. Bax's NPI, 1598254005, was assigned on May 9, 2018. Dr. Bax graduated from University at Buffalo School of Medicine in 2018. Dr. Bax holds New York license 323628.

Dr. Bax's primary practice is Breast Care of Western New York, at 3041 Orchard Park Rd, Orchard Park, NY 14127 in Erie County. The practice phone is (716) 634-3340.

Dr. Bax's primary practice is Breast Care of Western New York in Orchard Park, New York. Dr. Bax is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is Breast Care of Western New York. Dmand AI also links Dr. Bax to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bax practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Bax's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bax is licensed in New York.

CMS data shows 417 Medicare services from Dr. Bax across 11 procedure codes in 2024, for 161 Medicare patients. Medicare paid $41,967 for them. Every service was in an office.

CMS counts 161 Medicare patients who saw Dr. Bax in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bax's median patient age at 72, with 50% women.

In 2024, Dr. Bax wrote 433 Medicare Part D claims for 222 patients. 93% of them were for generic drugs. CMS names the drug for 333 of them, across 10 drugs with 11 or more claims each, at $7,994 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Dr. Bax accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 187 procedures of melanoma (skin cancer) excision by Dr. Bax, more than 97% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Bax, published from 2018 to 2023. 2018 was the busiest year, with 3. Dr. Bax has published most often in Dermatol Surg. Dr. Bax's most frequent co-authors are Todd Edgar Holmes, MD, Gyorgy Paragh, MD, PhD and Philomena M. Behar, MD.

CMS Open Payments shows 8 general payments to Dr. Bax from 7 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $121.

Dr. Bax graduated from University at Buffalo School of Medicine in 2018.